📣 VC round data is live. Check it out!
- Public Comps
- Jyong Biotech
Jyong Biotech Valuation Multiples
Discover revenue and EBITDA valuation multiples for Jyong Biotech and similar public comparables like Local Bounti, ABVC BioPharma, Above Food, Steakholder Foods and more.
Jyong Biotech Overview
About Jyong Biotech
Jyong Biotech Ltd is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). It has been dedicated to the research and development of new drugs with high safety and efficacy. It has been developing a series of drug candidates, including one core drug candidate at NDA stage, one clinical-stage key drug candidate and other preclinical-stage drug candidates.
Founded
2018
HQ

Employees
32
Website
Sectors
Financials (FY)
EV
$177M
Valuation Multiples
Start free trialJyong Biotech Financials
Jyong Biotech reported last fiscal year revenue of — and negative EBITDA of ($2M).
In the same fiscal year, Jyong Biotech generated ($2M) in EBITDA losses and had net loss of ($5M).
Jyong Biotech P&L
In the most recent fiscal year, Jyong Biotech reported revenue of — and EBITDA of ($2M).
Jyong Biotech is unprofitable as of last fiscal year, with EBITDA margin of — and net margin of —.
Financial data powered by Morningstar, Inc.
Jyong Biotech Stock Performance
Jyong Biotech has current market cap of $160M, and enterprise value of $177M.
Market Cap Evolution
Jyong Biotech's stock price is $2.15.
Jyong Biotech share price decreased by 5.3% in the last 30 days.
Jyong Biotech has an EPS (earnings per share) of $-0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $177M | $160M | 0.0% | -5.3% | 0.5% | — | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJyong Biotech Valuation Multiples
Jyong Biotech trades at (87.1x) EV/EBITDA.
Jyong Biotech Financial Valuation Multiples
As of May 26, 2026, Jyong Biotech has market cap of $160M and EV of $177M.
Jyong Biotech has a P/E ratio of (34.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Jyong Biotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Jyong Biotech Margins & Growth Rates
Jyong Biotech Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Jyong Biotech Operational KPIs
Jyong Biotech's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Jyong Biotech Competitors
Jyong Biotech competitors include Local Bounti, ABVC BioPharma, Above Food, Steakholder Foods, Moolec Science, Planethic Group, Next Meats Holdings, Oatly, Modern Plant Based Foods and Beyond Meat.
Most Jyong Biotech public comparables operate across Plant-Based Food.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 10.8x | 10.8x | (13.4x) | — | |||
| — | — | (4.4x) | — | |||
| 0.5x | — | (4.5x) | — | |||
| — | — | (0.5x) | — | |||
| 0.7x | — | (2.2x) | — | |||
| 1.3x | — | (6.0x) | — | |||
| — | — | — | — | |||
| 0.9x | 0.9x | 119.4x | 64.6x | |||
This data is available for Pro users. Sign up to see all Jyong Biotech competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Jyong Biotech
| When was Jyong Biotech founded? | Jyong Biotech was founded in 2018. |
| Where is Jyong Biotech headquartered? | Jyong Biotech is headquartered in Taiwan. |
| How many employees does Jyong Biotech have? | As of today, Jyong Biotech has over 32 employees. |
| Who is the CEO of Jyong Biotech? | Jyong Biotech's CEO is Fu-Feng Kuo. |
| Is Jyong Biotech publicly listed? | Yes, Jyong Biotech is a public company listed on Nasdaq. |
| What is the stock symbol of Jyong Biotech? | Jyong Biotech trades under MENS ticker. |
| When did Jyong Biotech go public? | Jyong Biotech went public in 2025. |
| Who are competitors of Jyong Biotech? | Jyong Biotech main competitors include Local Bounti, ABVC BioPharma, Above Food, Steakholder Foods, Moolec Science, Planethic Group, Next Meats Holdings, Oatly, Modern Plant Based Foods, Beyond Meat. |
| What is the current market cap of Jyong Biotech? | Jyong Biotech's current market cap is $160M. |
| Is Jyong Biotech profitable? | No, Jyong Biotech is not profitable. |
| How many companies Jyong Biotech has acquired to date? | Jyong Biotech hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Jyong Biotech has invested to date? | Jyong Biotech hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Jyong Biotech
Lists including Jyong Biotech
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.